Investigational deramiocel is back under FDA review again ...
Creatine, a compound often associated with gym-goers and athletes, has long been touted as a performance-enhancing supplement ...
Clinicians should be aware of claims being made about unregulated peptides and the potential harms associated with these ...
Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion clinical trial of PLN-101095 in combination with ...
Q1 2026 Earnings Call May 6, 2026 4:30 PM EDTCompany ParticipantsTamara Thornton - Director of Finance, Treasury ...
Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...
We often think of aging as something that just happens to us while we look the other way. In reality, the fountain of youth ...
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
This dairy powerhouse is packed with health benefits.
Understanding how muscle deteriorates could help researchers extend the human health span. “When you ask most older adults ...